Abstract
Background
Endoscopic radiofrequency ablation (RFA) has been used effectively for ablation of foregut disorders and also may have a role in treating colonic pathology. This study aimed to assess the feasibility of delivering RFA to locations within the colon and to determine a range of safe treatment parameters.
Methods
Patients undergoing left hemicolectomy or proctocolectomy were evaluated. Focal RFA using a colonoscope-mounted device was delivered to normal segments of the colon and rectum within the planned surgical resection specimen. Endoscopic accessibility and feasibility of delivering heat energy to the colon and rectum were assessed as well as the maximum incurred histologic depth of ablation in relation to the number of applications (2 or 4) and the energy density (12, 15, or 20 J/cm2).
Results
A total of 51 ablation zones in 16 patients had available histopathology. None of the sites receiving two applications demonstrated serosal layer alteration compared with 15% of the sites receiving four applications (p = 0.11). Muscularis propria alterations were seen in 25% of the two-application sites and 63% of the four-application sites (p < 0.05). Increasing energy density from 12 to 20 J/cm2 did not correlate with a deeper ablation effect.
Conclusions
Endoscopic RFA is capable of delivering therapy to the distal colon. Injury is limited to the muscularis propria or less depth when no more than two ablations are applied regardless of the energy density used. Based on these feasibility and dosimetry results, the authors will continue investigation using these and smaller energy doses to initiate trials ultimately with patients who have suitable mucosal and submucosal disorders of the lower gastrointestinal tract including chronic, nonulcerated hemorrhagic radiation proctitis and angiodyplasia.
Similar content being viewed by others
References
Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P (2004) Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60:1002–1010
Dunkin BJ, Martinez J, Bejarano PA, Smith CD, Chang K, Livingstone AS et al (2006) Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 20:125–130
Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ et al (2007) Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65:185–195
Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE (2008) A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 40:380–387
Ganz RA, Overholt BF, Sharma VK, Fleischer DE, Shaheen NJ, Lightdale CJ et al (2008) Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. multicenter registry. Gastrointest Endosc 68(1):35–40
Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD et al (2008) Stepwise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 40:359–369
Pouw RE, Gondrie JJ, Curvers WL, Sondermeijer CM, Ten Kate FJ, Bergman JJ (2008) Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. Gastrointest Endosc 68(3):537–541
Gross SA, Al-Haddad M, Gill KR, Schore AN, Wallace MB (2008) Endoscopic mucosal ablation for the treatment of gastric antral vascular ectasia with the HALO90 system: a pilot study. Gastrointest Endosc 67:324–327
de Parades V, Etienney I, Bauer P, Bourguignon J, Meary N, Mory B et al (2005) Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis: an effective but not risk-free procedure: a prospective study of 33 patients. Dis Colon Rectum 48:1535–1541
Parikh S, Hughes C, Salvati EP, Eisenstat T, Oliver G, Chinn B et al (2003) Treatment of hemorrhagic radiation proctitis with 4 percent formalin. Dis Colon Rectum 46:596–600
Dall’Era MA, Hampson NB, Hsi RA, Madsen B, Corman JM (2006) Hyperbaric oxygen therapy for radiation-induced proctopathy in men treated for prostate cancer. J Urol 176:87–90
Prost B, Poncet G, Scoazec JY, Saurin JC (2004) Unusual complications of argon plasma coagulation. Gastrointest Endosc 59:929–932
Olmos JA, Marcolongo M, Pogorelsky V, Herrera L, Tobal F, Davolos JR (2006) Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia. Dis Colon Rectum 49:1507–1516
Jones K, Evans AW, Bristow RG, Levin W (2006) Treatment of radiation proctitis with hyperbaric oxygen. Radiother Oncol 78:91–94
Araki K, Furuya Y, Kobayashi M, Matsuura K, Ogata T, Isozaki H (1996) Comparison of mucosal microvasculature between the proximal and distal human colon. J Electron Microsc Tokyo 45:202–206
Polychronidis A, Tsaroucha AK, Karayiannakis AJ, Perente S, Efstathiou E, Simopoulos C (2005) Delayed perforation of the large bowel due to thermal injury during laparoscopic cholecystectomy. J Int Med Res 33:360–363
Acknowledgments
This study was conducted with financial support through research funding from BÂRRX Medical Inc. (Sunnyvale, CA). No investigator participating in this study has any financial relationship or received outside funding from this or any other company for performing this study.
Disclosures
Bradley J. Champagne is a consultant for Covidien and Ethicon and a speaker for Adolor/GSK. Conor P. Delaney received research funding from Adolor/GSK and Covidien. He lectures for Adolor/GSK and Covidien and serves as a consultant for Adolor/GSK, Ethicon, Covidien, and W.L. Gore. Jeffrey M. Marks has received honoraria from Covidien, Olympus, Boston Scientific, W.L. Gore, Ethicon, and Apollo Endosurgery and serves a consultant to all these firms. He is as an advisory board member for Apollo Endosurgery. Joseph A.Trunzo, Michael F. McGee, Benjamin K. Poulose, Joseph E. Willis, Bridget Ermlich, Michelle Laughinghouse have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trunzo, J.A., McGee, M.F., Poulose, B.K. et al. A feasibility and dosimetric evaluation of endoscopic radiofrequency ablation for human colonic and rectal epithelium in a treat and resect trial. Surg Endosc 25, 491–496 (2011). https://doi.org/10.1007/s00464-010-1199-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-010-1199-3